Huntington’s Disease and Mitochondrial DNA Deletions: Event or Regular Mechanism for Mutant Huntingtin Protein and CAG Repeats Expansion?! (original) (raw)
References
Arenas J, Campos Y, Ribacoba R, Martin MA, Rubio JC, Ablanedo P, Cabello A (1998) Complex I defect in muscle from patients with Huntington’s disease. Ann Neurol 43:397–400 ArticlePubMedCAS Google Scholar
Bezprovanny I, Hayden MR (2004) Deranged neuronal calcium singnaling and Huntington disease. Bioch Biophy Res Comm 322:1310–1317 ArticleCAS Google Scholar
Cha JH (2000) Transcriptional dysregulation in Huntington’s disease. Trends Neurosci 23:387–392 ArticlePubMedCAS Google Scholar
Chang DTW, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobio Dis 22:388–400 ArticleCAS Google Scholar
Cooper JK, Schilling G, Peters MF, Herring WJ, Sa H, Kaminsky Z, Masone J, Khan FA, Delanoy M, Borchelt DR, Dawson VL, Dawson TM, Ross CA (1998) Truncated N- terminal fragment of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 7:783–790 ArticlePubMedCAS Google Scholar
Costa Mdo C, Teixeira-Castro A, Constante M, Magalhaes M, Magalhaes P, Cerqueira J, Vale J, Passao V, Barbosa C, Robalo C, Coutinho P, Barros J, Santos MM, Sequeiros J, Maciel P (2006) Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet 51:645–651 ArticlePubMedCAS Google Scholar
Fesahat F, Houshmand M, Panahi MSS, Gharagozli K, Mirzajani F (2007) Do haplogroups h and u act to increase the penetrance of Alzheimer’s disease? Cell Mol Neurobiol 27:329–334 ArticlePubMedCAS Google Scholar
Hazeki N, Nakamura K, Goto J, Kanazawa I (1999) Rapid aggregate formation of the huntingtin N-terminal fragment carrying an expanded polyglutamine tract. Biochem Biophys Res Commun 256:361–366 ArticlePubMedCAS Google Scholar
Hirano M, Marti R, Ferreiro-Barros C, Vila MR, Tadesse S, Nishigaki Y, Nishino I, Vu TH (2001) Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA. Semin Cell Dev Biol 12:417–427 ArticlePubMedCAS Google Scholar
Hormozian F, Houshmand M, Sanati MH, Ghiasvand M, Banoei MM (2004) Molecular analysis of (CAG)n repeat causing Huntington’s disease in 34 Iranian families. Ind J Hum Genet 10:53–57 CAS Google Scholar
Horton TM, Graham BH, Corral-Debrinski M, Shoffner JM, Kaufman AE, Beal MF, Wallace DC (1995) Marked increase in mitochondrial DNA deletion levels in the cerebral cortex of Huntington’s disease patients. Neurology 45:1879–1883 PubMedCAS Google Scholar
Houshmand M, Panahi MSS, Fesahat F, Gharagozli K (2007) Lack of association between mitochondrial A4336G /haplogroup and Parkinson’s disease. Chinese J Clin Med 2:259–265 CAS Google Scholar
Houshmand M, Panahi MSS, Nafisi S, Soltanzadeh A, Alkandari FM (2006) Identification and sizing of GAA trinucleotide repeat expansion, investigation for D-loop variations and mitochondrial deletions in Iranian patients with Friedreich’s ataxia. Mitochondrion 6:82–88 ArticlePubMedCAS Google Scholar
Krausz C, Guarducci E, Becherini L, Degl’Innocenti S, Gerace L, Balercia G, Forti G (2004) The clinical significance of the POLG gene polymorphism in male infertility. J Clin Endocrinol Metab 89:4292–4297 ArticlePubMedCAS Google Scholar
Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM, Ferrante RJ (1999) Huntington aggregates may not predict neuronal death in Huntington’s disease. Ann Neurol 46:842–849 ArticlePubMedCAS Google Scholar
Manfredi G, Xu Z (2005) Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5:77–87 ArticlePubMedCAS Google Scholar
Matrin JB (1999) Molecular basis of neurodegenerative disorders. New Eng J Med 340:1970–1980 Article Google Scholar
Mawrin C, Kirches E, Krause G, Schneider-Stock R, Bogerts B, Vorwerk CK, Dietzmann K (2004) Region-specific analysis of mitochondrial DNA deletions in neurodegenerative disorders in humans. Neurosci Lett 357:111–114 ArticlePubMedCAS Google Scholar
Meade CA, Deng YP, Fusco FR, Del Mar N, Hersch S, Goldowitz D, Reiner A (2002) Cellular localization and development of neuronal intranuclear inclusions in striatal and cortical neurons in R6/2 transgenic mice. J Comp Neurol 449:241–269 ArticlePubMed Google Scholar
Moslemi AR, Melberg A, Holme E, Oldfors A (1996) Clonal expansion of mitochondrial DNA with multiple deletions in autosomal dominant progressive external ophthalmoplegia. Ann Neurol 40:707–713 ArticlePubMedCAS Google Scholar
Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF Jr, Greenamyre JT, Snyder SH, Ross CA (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194–1198 ArticlePubMedCAS Google Scholar
Schapira AH (2002) The “new” mitochondrial disorders. J Neurol Neurosurg Psychiatry 72:144–149 ArticlePubMedCAS Google Scholar
Schapira AHV (1999) Mitochondrial involvement in Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia and Friedreich’s ataxia. Biochim Biophys Acta 1410:159–170 ArticlePubMedCAS Google Scholar
Schffer IE (2000) A century mitochondrial research: achievements and perspectives. Mitochondrion 1(1):3–31 Google Scholar
Schon EA, Manfredi G (2003) Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 111:303–312 ArticlePubMedCAS Google Scholar
Squitieri F, Cannella M, Sgarbi G, Maglione V, Falleni A, Lenzi P, Baracca A, Cislaghi G, Saft C, Ragona G, Russo MA, Thompson LM, Solaini G, Fornai F (2006) Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Aging Dev 127:217–220 ArticlePubMedCAS Google Scholar
Stevanin G, Fujigasaki H, Lebre AS, Camuzat A, Jeannequin C, Dode C, Takahashi J, San C, Bellance R, Brice A, Durr A (2003) Huntington’s disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126:1599–1603 ArticlePubMed Google Scholar
Taanman JW, Schapira AH (2005) Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson’s disease. Neurosci Lett 376:56–59 ArticlePubMedCAS Google Scholar
Tabrizi SJ, Schapira AH (1999) Secondary abnormalities of mitochondrial DNA associated with neurodegeneration. Biochem Soc Symp 66:99–110 PubMedCAS Google Scholar
Truant R (2003) Nucleocytoplasmic transport of huntingtin and Huntington’s disease. Clin Neurosci Res 3:157–164 ArticleCAS Google Scholar
Valabrese V, Lodi R, Tonon C, D’agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Giuffrida Stella AM, Butterfield DA (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich’s ataxia. J Neuro Sci 233:145–162 ArticleCAS Google Scholar
Van Roon-Mom WMC, Reid SJ, Faull RLM, Snell RG (2005) TATA binding protein in neurodegenerative disease. Neurosci 133:863–872 ArticleCAS Google Scholar
Wallace DC (1994) Mitochondrial DNA sequence variation in human evolution and disease. Proc Nat Acad Sci USA 91:8739–8746 ArticlePubMedCAS Google Scholar
Wallace DC (1999) Mitochondrial disease in man and mouse. Science 283:483–488 Article Google Scholar
Wallace DC, Shoffner JM, Trounce I, Brown MD, Ballinger SW, Corral-Debrinski M, Horton T, Jun AS, Lott MT (1995) Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim Biophys Acta 1271(1):141–151 PubMed Google Scholar
Wanagat J, Cao Z, Pathare P, Aiken JM (2001) Mitochondrial DNA deletion mutations colocalize with segmental electron transport system abnormalities, muscle fiber atrophy, fiber splitting and oxidative damage in sarcopenis. FASEB 15:323–332 Article Google Scholar
Wang ZC, Wang XM, Jiao BH, Jin YX, Miao MY, Zhu KJ (2003) Detection of mitochondrial DNA deletion by a modified PCR method in a Co radiation- exposed patient. IUBMB Life 55:133–137 ArticlePubMedCAS Google Scholar